China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
China
· Delayed Price · Currency is CNY 18.11
-0.09 (-0.49%)
At close: Mar 9, 2026
SHA:600062 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 18,700 | 20,323 | 18,992 | 18,276 | 13,948 | 12,508 | Upgrade
|
| Market Cap Growth | -6.86% | 7.01% | 3.92% | 31.03% | 11.51% | -8.12% | Upgrade
|
| Enterprise Value | 18,289 | 19,024 | 16,381 | 16,124 | 11,180 | 9,405 | Upgrade
|
| Last Close Price | 18.11 | 19.31 | 17.80 | 16.83 | 12.08 | 10.57 | Upgrade
|
| PE Ratio | 11.83 | 12.49 | 11.37 | 15.49 | 14.91 | 12.44 | Upgrade
|
| Forward PE | 10.63 | 11.03 | 12.46 | 15.32 | 11.70 | 9.97 | Upgrade
|
| PS Ratio | 1.71 | 1.81 | 1.68 | 1.90 | 1.53 | 1.47 | Upgrade
|
| PB Ratio | 1.54 | 1.83 | 1.47 | 1.61 | 1.33 | 1.33 | Upgrade
|
| P/TBV Ratio | 2.21 | 2.61 | 1.99 | 2.29 | 1.76 | 1.69 | Upgrade
|
| P/FCF Ratio | 19.48 | 17.11 | 15.26 | 20.55 | 16.42 | 12.36 | Upgrade
|
| P/OCF Ratio | 12.39 | 11.14 | 10.22 | 12.91 | 10.40 | 9.20 | Upgrade
|
| PEG Ratio | - | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | Upgrade
|
| EV/Sales Ratio | 1.67 | 1.70 | 1.45 | 1.68 | 1.23 | 1.11 | Upgrade
|
| EV/EBITDA Ratio | 7.48 | 8.07 | 6.85 | 9.07 | 7.55 | 6.08 | Upgrade
|
| EV/EBIT Ratio | 11.01 | 11.59 | 9.49 | 13.03 | 10.81 | 8.02 | Upgrade
|
| EV/FCF Ratio | 19.05 | 16.02 | 13.16 | 18.13 | 13.16 | 9.29 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.11 | 0.02 | 0.03 | 0.01 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.47 | 0.51 | 0.13 | 0.16 | 0.04 | - | Upgrade
|
| Debt / FCF Ratio | 1.21 | 1.03 | 0.25 | 0.33 | 0.07 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.10 | -0.15 | -0.24 | -0.22 | -0.34 | -0.35 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.51 | -0.69 | -1.32 | -1.43 | -2.42 | -2.11 | Upgrade
|
| Net Debt / FCF Ratio | -1.30 | -1.37 | -2.53 | -2.86 | -4.21 | -3.22 | Upgrade
|
| Asset Turnover | 0.65 | 0.64 | 0.68 | 0.67 | 0.70 | 0.72 | Upgrade
|
| Inventory Turnover | 2.93 | 2.95 | 2.73 | 2.42 | 2.74 | 2.59 | Upgrade
|
| Quick Ratio | 1.64 | 1.41 | 1.56 | 1.79 | 2.08 | 2.02 | Upgrade
|
| Current Ratio | 2.25 | 1.87 | 1.96 | 2.48 | 2.76 | 2.55 | Upgrade
|
| Return on Equity (ROE) | 14.12% | 13.75% | 13.74% | 11.32% | 9.79% | 11.23% | Upgrade
|
| Return on Assets (ROA) | 6.37% | 5.88% | 6.46% | 5.36% | 4.95% | 6.19% | Upgrade
|
| Return on Invested Capital (ROIC) | 13.94% | 15.09% | 16.00% | 13.57% | 13.72% | 16.11% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.40% | 12.90% | 12.90% | 10.20% | 9.40% | 12.00% | Upgrade
|
| Earnings Yield | 8.45% | 8.01% | 8.79% | 6.46% | 6.71% | 8.04% | Upgrade
|
| FCF Yield | 5.13% | 5.84% | 6.55% | 4.87% | 6.09% | 8.09% | Upgrade
|
| Dividend Yield | 2.59% | 2.44% | 1.44% | 3.44% | 3.97% | 2.74% | Upgrade
|
| Payout Ratio | 51.41% | 90.88% | 18.31% | 67.94% | 32.34% | 31.77% | Upgrade
|
| Buyback Yield / Dilution | -0.57% | -0.33% | 1.07% | 0.74% | 0.00% | -0.00% | Upgrade
|
| Total Shareholder Return | 2.01% | 2.11% | 2.52% | 4.18% | 3.97% | 2.74% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.